Slide 1: HY 2022 Results Presentation
For personal use only HY 2022 RESULTS PRESENTATION February 2022
Slide 2: Pro Medicus (ASX:PME)
PRO MEDICUS (ASX:PME) Healthcare IT company specializing in Enterprise Imaging and For personal use only Radiology Information System (RIS) software. Leading edge products, growing global presence. EU HQ/R&D Berlin GmbH U.S. HQ San Diego CA GROUP HQ Melbourne AUS OVER 40+ SOFTWARE ENGINEERS 2
Slide 3: Product Suite
ASX:PME For personal use only VISAGE RIS VISAGE 7 OEM PRODUCT SUITE 3
Slide 4: Results HY 2022
RESULTS HY 2022 For personal use only $44.3M $20.67M $28.80M 65% Underlying Profit Underlying EBIT Revenue after tax Profit margins up 40.3% up 52.7% Before Tax up 53.5% $76.17 $0.10 Cash Company Strong Full year & debt balance dividend FF Investments free sheet Up 42.9% up 23.2.%
Slide 5: Highlights HY22
Highlights HY22 For personal use only University of German Government California $1.3M Capital $12M/5 years $40M/7 years license UCSF Continues to grow New Contract Fully Deployed Contract Renewal Fully Deployed New Contract STRONGLY JULY SEPTEMBER/OCTOBER OCTOBER DECEMBER DECEMBER CURRENT 2021 2021
Slide 6: Novant Health
NOVANT HEALTH For personal use only • $40M – 7-year contract • Equal biggest deal to date • Cloud based implementation • Visage to replace multiple legacy PACS systems • Visage to deploy Visage 7 Workflow and Visage 7 Viewer • Extends PME’s rapidly growing footprint in IDN Market • Transaction-based
Slide 7: German Government Contract
GERMAN GOVERNMENT CONTRACT For personal use only • 4th extension of original contract signed in 2015 • $1.3M one-off capital license (net of hardware) • Annual support contract to be in addition • Increases PME footprint in Europe 7
Slide 8: Allegheny Health - Renewal
ALLEGHENY HEALTH - Renewal For personal use only • 5-year renewal – same term as original contract • $12M over 5 years at minimums • Increased cost per transaction • Upside as AHN grows • Confirms confidence in Visage offering 8
Slide 9: HY 2022 Revenue Split
HY 2022 REVENUE SPLIT For personal use only
Slide 10: Operational (Transaction) Model
OPERATONAL (TRANSACTION) MODEL For personal use only • Used in vast majority of US contracts • Delivered as SaaS model • Now used in RIS contracts in AUS • Model based on transaction minimums • Forward revenue > A$382M/5 years* • Upside as client examination volumes grow • Annuity style revenue stre
Slide 11: Exam (Transaction) Revenue
EXAM (TRANSACTION) REVENUE For personal use only • Recurring in nature • Increased by ~ 37% PoP • Growth to continue for FY 2022 (Intermountain, UCSF & others) • New sites coming online in 2nd Half FY22 (UC Irvine, UCSD & UVM) • Growth from existing clients (organic and M&A) plus new clients • Furth
Slide 12: Professional Services
PROFESSIONAL SERVICES For personal use only • Project planning, training & implementation • Revenue spread over the length of the contract - new accounting standards (AASB 15) • Recurring in nature ~ 10% contract value • Data migration as part of Visage 7 Open Archive sale – once off 12
Slide 13: Operating Leverage
OPERATING LEVERAGE For personal use only • Highly scalable offering • No capex (HW) – SW only model • Training & Installation – charged as professional services • Contained cost base • High operating leverage • Margin continues to grow as footprint increases 13
Slide 14: COVID-19
COVID-19 For personal use only • PME/Visage still largely WFH • Operating at 100% capacity • Sales and marketing efforts continued throughout • “Thinness” of the technology enabled large scale remote demonstrations • New opportunities despite COVID restrictions • Visage 7 - enables radiologists to s
Slide 15: Visage RIS
For personal use only VISAGE RIS
Slide 16: Visage RIS
VISAGE RIS For personal use only • Long term (5 year) contracts with Primary Healthcare and I–MED, the 2 biggest radiology providers in AUS • HIS (Healius) rollout now complete • Upside via organic and M&A growth • Increased market interest – new opportunities • PME undisputed market leader
Slide 17: Visage: #1 in Speed, Functionality and Scalability
VISAGE 7 For personal use only Continues to be #1 in Speed, Functionality and Scalability SPEED FUNCTIONALITY SCALABILITY
Slide 18: Massive Data Explosion
MASSIVE DATA EXPLOSION For personal use only • High density Multi-slice CT - 10,000+ images • HD Breast Tomosynthesis - 6 GB+ • Optoacoustic Breast Ultrasound - 10+ GB • Total Body PET Scan - 10+ GB • 7T MRI - much larger than 3T
Slide 19: Legacy Technology
LEGACY TECHNOLOGY For personal use only “Compress and Send” MODALITIES PACS RADIOLOGIST/CLINICIAN
Slide 20: Solution: Visage Streaming Technology
SOLUTION For personal use only VISAGE 7 Streaming Technology BACKEND RENDER SERVER SERVER RADIOLOGIST/CLINICIAN MODALITIES
Slide 21: Fast Track Implementation
FAST TRACK IMPLEMENTATION For personal use only • All implementations on or ahead of schedule • Fast track methodology continues to deliver • Large scale projects completed in under 1/4 the time of industry norm • Delivers huge savings for client • Frees PME staff for other jobs • Reduces barrier to
Slide 22: Visage - Proven ROI
VISAGE – PROVEN ROI For personal use only Significant IT & Unparalleled Increase in Greater Clinical Infrastructure Savings Radiologist Efficiency Accuracy Improved Physician Delivers Superior Engagement Value Proposition 22
Slide 23: Clinical Outcomes
Clinical Outcomes For personal use only Moving the Needle 23
Slide 24: Visage - Clinical ROI
VISAGE – CLINICAL ROI For personal use only Improved Physician Engaement 24
Slide 25: Remote mammogram reading improves equity
Doctors, spurred by the pandemic, try to make breast cancer screening easier and faster By Felice J. Freyer Globe Staff,Updated July 10, 2021, 3:07 p.m. For personal use only • 15 percent of patients got their mammograms read instantly – mostly white women with higher incomes. • We had unintentional
Slide 26: Radiogenomics of Pediatric Brain Tumors
Radiogenomics of Pediatric Brain Tumors – Purpose For personal use only • ~ 4,170 new cases in US in 2022, with median survival in primary malignant brain and other CNS tumors being 8 months for glioblastoma and up to 16.6 yrs for oligodendrogliomas • Grading and classification of brain tumors is ve
Slide 27: Growth Strategy
GROWTH STRATEGY For personal use only New product offerings Transaction growth Extend to new from existing clients geographical markets Leverage R&D capability Expand footprint – to introduce next new clients generation products 27
Slide 28: North American Pipeline
NORTH AMERICAN PIPELINE For personal use only Prospects Progressing through Network Effect various stages of the cycle Opportunities Increased as a result of recent high- profile wins Last 12 months - Pipeline Robust significant increase in number of inbound RFPs In terms of quality and quantity of
Slide 29: Visage Open Archive
VISAGE 7 OPEN ARCHIVE For personal use only • Same highly scalable Visage 7 platform • Interoperable – works in complex environments • Enables choice of modular or single vendor solutions • Three recent sales - Viewer and Visage 7 Open Archive • Pipeline includes Visage 7 Open Archive opportunities
Slide 30: Visage Workflow
VISAGE 7 WORKFLOW For personal use only • Adds to Visage 7 Viewer and Open Archive modules • Based on over 30 years experience in Worklist SW • Allows PME to offer single vendor solution • Integral part of Visage in the Cloud SaaS solution • Ability to interface with broad range of AI algorithms • T
Slide 31: New Products
NEW PRODUCTS For personal use only • Single viewer for ALL images in the medical record (EMR) • Radiology/Cardiology (DICOM format) • Non-radiology– reflected light – hi-res photos & videos • Visage 7 technology ideally suited • Increases Visage value proposition • Growth opportunities within existi
Slide 32: Visage in the Cloud
Visage in the Cloud For personal use only • Visage 7 – fully Cloud native • Same ultrafast performance as on-premise • Full Visage 7 functionality • Security and scale of the cloud • Complete PACS deployment or as backup/disaster recovery • Suitable for all size implementations • Opens new market op
Slide 33: Visage in the Cloud - Cloud Native
VISAGE® 7 IN THE CLOUD CLOUD NATIVE » Object Storage “ MASSIVELY PARALLEL 1/0 Digital Alchemy for Imaging in the Cloud Faster-than flash performance using secure, low-cost storage. We re-architected Vi intelligently leverage the best capabilities of object-based cloud storage. Up to 60) to cloud obj
Slide 34: Visage Unique End to End Solution
VISAGE 7 For personal use only • Unique end to end solution • Supports both research and production environments on a single platform • Based on market leading Visage 7 technology • Enables Visage clients to fast-track AI as part of their imaging strategy 34
Slide 35: Visage AI Accelerator Platform
VISAGE 7 For personal use only • Visage AI Accelerator Platform – streamlines AI algorithm development • Optimised for AI data curation and validation • Open API - seamless integration • AI Ecosystem - 3rd party and Visage developed algorithms • Joint development/commercialisation opportunities - 3r
Slide 36: AI Research Leadership
AI Research Leadership For personal use only Malte Westerhoff, PhD Global Chief Technology Officer Detlev Stalling, PhD Head of Development Ming De Lin, PhD Clinical Research Manager North America Raj Moily, MBBS, PhD Director, AI Business Development North America 36
Slide 37: Research Collaboration Agreements (RCA)
RESEARCH COLLABORATION AGREEMENTS (RCA) For personal use only 37
Slide 38: Breast Density - AI
BREAST DENSITY - AI For personal use only • First diagnostic AI algorithm produced by Visage • Developed in collaboration with breast imaging team at Yale • Provides “on-the-fly” AI assessment of breast density • Previewed at RSNA 2019 as WIP • FDA clearance – February 2021 • A model for future AI d
Slide 39: Solution: Visage Streaming Technology
SOLUTION: Visage 7 Streaming Technology For personal use only
Slide 40: Thank You
For personal use only THANK YOU